Search by Drug Name or NDC

NDC 72789-0025-21 BENZONATATE 200 mg/1 Details

BENZONATATE 200 mg/1

BENZONATATE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is BENZONATATE.

MedlinePlus Drug Summary

Benzonatate is used to relieve cough. Benzonatate is in a class of medications called antitussives (cough suppressants). It works by reducing the cough reflex in the lungs and air passages.

Related Packages: 72789-0025-21
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Benzonatate

Product Information

NDC	72789-0025
Product ID	72789-025_fda53e8a-6e89-9dce-e053-6394a90a3644
Associated GPIs	43102010000110
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	BENZONATATE
Proprietary Name Suffix	n/a
Non-Proprietary Name	BENZONATATE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	200
Active Ingredient Units	mg/1
Substance Name	BENZONATATE
Labeler Name	PD-Rx Pharmaceuticals, Inc.
Pharmaceutical Class	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA040682
Listing Certified Through	2024-12-31

Package

NDC 72789-0025-21 (72789002521)

Pricing Information	N/A
NDC Package Code	72789-025-21
Billing NDC	72789002521
Package	21 CAPSULE in 1 BOTTLE, PLASTIC (72789-025-21)
Marketing Start Date	2019-11-04
NDC Exclude Flag	N